Market Place
Sourcing Support
All News #Library
Others
Turnstone At BofA Securities Healthcare Conference 2024
08 May 2024 //
GLOBENEWSWIRE
Turnstone to Participate in the Piper Sandler 35th Annual Healthcare Conference
27 Nov 2023 //
GLOBENEWSWIRE
Turnstone Presents Data Highlighting Potential for TIL Therapy in Solid Tumors
03 Nov 2023 //
GLOBENEWSWIRE
Turnstone Biologics Enters Agreement with the National Cancer Institute
29 Nov 2022 //
BUSINESSWIRE
Turnstone Biologics to Present Preclinical Data From Novel TIL Therapy
08 Nov 2022 //
BUSINESSWIRE
Turnstone Biologics Announces FDA Clearance of IND for TIDAL-01
31 Oct 2022 //
BUSINESSWIRE
Takeda axes clinical-stage program in $1B+ Turnstone Biologics collaboration
29 Jul 2022 //
ENDPTS
Turnstone and Moffitt Cancer Center Announce Strategic Alliance for Solid Tumors
06 Jul 2022 //
BUSINESSWIRE
2seventy bio plucks Turnstone exec Bernstein to be new CMO
15 Feb 2022 //
FIERCEBIOTECH
Turnstone Biologics Raises $80 Million Series D Financing
21 Jul 2021 //
BUSINESSWIRE
Turnstone rounds up $80M to fly immunotherapies through clinic
21 Jul 2021 //
FIERCEBIOTECH
Turnstone Biologics Raises $80 Million Series D Financing
20 Jul 2021 //
BUSINESSWIRE
Turnstone buys Myst to add tumor-infiltrating lymphocyte assets
20 Jan 2021 //
FIERCEBIOTECH
Turnstone buys Myst to add tumor-infiltrating lymphocyte assets
20 Jan 2021 //
FIERCEBIOTECH
Turnstone Biologics Announces First Patient Ph1/2 Trial Evaluating RIVAL-01
01 Dec 2020 //
BUSINESSWIRE
Turnstone Announces First Patients Enrolled in Ph 1/2 Trial RIVAL-01
01 Dec 2020 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.